Weekly Policy Update: Legislative Session Closes – CBSA Reviews Policy Accomplishments

The 2022 legislative session, the Second Regular Session of the 73rd General Assembly, has concluded. It was an unprecedented session that  began with the legislature having significant financial...

Learn More

Weekly Policy Update: Legislative Session Comes to a Close This Week

The legislative session is scheduled to end this Wednesday, May 11th. As we enter these final three days, the CBSA team continues to weigh in on key legislation and advocate on behalf of our life scie...

Learn More

Weekly Policy Update: Legislative Session Enters the Final Weeks

The legislative session is scheduled to end on Wednesday, May 11th, or in about 12 days. As we enter the final stretch, the CBSA team continues to weigh in on key legislation and advocate on behalf of...

Learn More

Weekly Policy Update: Congressional Tax Package Could Support Further Industry Growth

CBSA is committed to keeping our community updated on issues that impact life sciences. Our Policy + Advocacy team is reviewing newly proposed legislation that could directly affect life sciences comp...

Learn More

Weekly Policy Update: Medical Device User Fee Amendments (MDUFA)

CBSA and our national partners support the renewal of the critically important Medical Device User Fee Amendments (MDUFA). After months of negotiations among the FDA and industry advocacy groups, incl...

Learn More

Weekly Policy Update: Small Business Innovation Research and Small Business Technology Transfer Programs

A longstanding policy priority for CBSA is supporting our ecosystem’s need for increased access to capital. Through our Capital + Growth efforts, we work closely with public and private partners to ac...

Learn More

Weekly Policy Update: TRIPS Waiver Update

Colorado BioScience Association continues to monitor the international debate on the Trade-Relations Aspects of Intellectual Property Rights (TRIPS) Waiver, due the harmful precedent the waiving of IP...

Learn More

Weekly Policy Update: Advocacy on Congressional Tax and Investment Policies

Colorado BioScience Association is watching legislative proposals at the federal level that would be harmful to business. These proposals would have impacts on Qualified Small Business Stock and tax c...

Learn More

Weekly Policy Update: State Regulation of PFAS

The regulatory environment regarding the usage of perfluoroalkyl and polyfluoroalkyl chemicals (PFAS) in medical devices and other products is evolving to include potential action on the state level....

Learn More

Weekly Policy Update: Accelerated Approvals Reform Bill Introduced

CBSA is committed to keeping our community updated on issues that impact life sciences. Our Policy + Advocacy team is reviewing newly proposed legislation that could directly affect life sciences comp...

Learn More